-+ 0.00%
-+ 0.00%
-+ 0.00%

Serina Therapeutics CEO presents on SER-252 Parkinson’s program in Tribe Public webinar Q&A

PUBT·09/23/2026 20:19:07
Listen to the news
Serina Therapeutics CEO presents on SER-252 Parkinson’s program in Tribe Public webinar Q&A
  • Serina Therapeutics’ CEO Steven Ledger will present at a Tribe Public webinar on Sept. 24, 2026.
  • Session starts 8:30 a.m. PST, 11:30 a.m. ET, focusing on SER-252 clinical progress in advanced Parkinson’s disease.
  • Event includes a live Q&A segment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609231618PRIMZONEFULLFEED9832825) on September 23, 2026, and is solely responsible for the information contained therein.